While GAL1 is also present in the tumor stroma (Chou et al, 2018), research has indicated that tumor‐derived, rather than TME‐derived GAL1, is involved in the aggressiveness of glioma progression (Verschuere et al, 2014). Here, LGALS1 is linked to central nervous system cancer.